1. HIV-associated cancers: the role of a unique multidisciplinary board to optimize patient’s care behalf the CANCERVIH Group

   • Aurelien Gobert
   • Jean-Philippe Spano
   • Jacques Cadranel

   Letter to the Editor 05 December 2018 Article: 13

2. IL-39 acts as a friend to pancreatic cancer

   • Alicia A. Manning
   • Lei Zhao
   • Yujiang Fang

   Original Paper 01 December 2018 Article: 12

   

3. Isocitrate dehydrogenase gene mutations and 2-hydroxyglutarate accumulation in esophageal squamous cell carcinoma

   • Keisuke Miyake
   • Yoshifumi Baba
   • Hideo Baba

   Original Paper 30 November 2018 Article: 11

   

4. Fluorescence in situ hybridization in 1 mL of selective urine for the detection of upper tract urothelial carcinoma: a feasibility study

   • J. E. Freund
   • E. I. M. L. Liem
   • T. M. de Reijke

   Short Communication Open access 29 November 2018 Article: 10

5. Impact of image guidance on toxicity and tumour outcome in moderately hypofractionated external-beam radiotherapy for prostate cancer

   • B. A. Jereczek-Fossa
   • A. Maucieri
   • R. Orecchia

   Original Paper 27 November 2018 Article: 9

   

6. The roles of PTEN, cMET, and p16 in resistance to cetuximab in head and neck squamous cell carcinoma

   • Alexandre A. B. A. da Costa
   • Felipe D’Almeida Costa
   • Vladmir Cláudio Cordeiro de Lima

   Original Paper 26 November 2018 Article: 8

   

7. Postoperative weight loss followed by radical cystectomy predicts poor prognosis in patients with muscle-invasive bladder cancer

   • Kazutaka Okita
   • Shingo Hatakeyama
   • Chikara Ohyama

   Original Paper 26 November 2018 Article: 7

   

8. Comparison of axitinib and sunitinib as first-line therapies for metastatic renal cell carcinoma: a real-world multicenter analysis

   • Sakae Konishi
   • Shingo Hatakeyama
   • Chikara Ohyama

   Original Paper 24 November 2018 Article: 6

   

9. The c-MYC/NAMPT/SIRT1 feedback loop is activated in early classical and serrated route colorectal cancer and represents a therapeutic target

   • Lydia Brandl
   • Nina Kirstein
   • Antje Menssen

   Original Paper 20 November 2018 Article: 5

   

10. Radiotherapy with the anti-programmed cell death ligand-1 immune checkpoint blocker avelumab: acute toxicities in triple-negative breast cancer

    • Eliana La Rocca
    • Michela Dispinzieri
    • Maria Carmen De Santis

    Short Communication 15 November 2018 Article: 4

    

11. Unraveling KDM4 histone demethylase expression and its association with adverse cytogenetic findings in chronic lymphocytic leukemia

    • Luma Dayane de Carvalho Filiú-Braga
    • Teresa Raquel Tavares Serejo
    • Felipe Saldanha-Araujo

    Short Communication 13 November 2018 Article: 3

    

12. Multidisciplinary team in head and neck cancer: a management model

    • F. De Felice
    • V. Tombolini
    • A. Polimeni

    Review Article 13 November 2018 Article: 2

    

13. Plasma levels of interleukin-33 and soluble suppression of tumorigenicity 2 in patients with advanced pancreatic ductal adenocarcinoma undergoing systemic chemotherapy

    • Markus Kieler
    • Matthias Unseld
    • Gerald W. Prager

    Original Paper Open access 13 November 2018 Article: 1